Colorectal cancer classification with differential prognosis and personalized therapeutic responses

The present invention relates to gene sets, the expression levels of which are useful for classifying colorectal tumors and predicting disease-free prognosis and response of patients to specific therapies that are either novel or currently available in the clinics for colorectal cancer patients.


  • There is no available fulltext. Please contact the lab or the authors.

Related material